`

OncoResponse

Research

revenue-icon Revenue
1M - 10M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About OncoResponse

What does Oncoresponse do?+

OncoResponse is a clinical stage, privately held immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite cancer responders. In a broad strategic alliance with MD Anderson Cancer Center, OncoResponse deploys a proprietary B-cell discovery platform to identify and develop novel therapeutics targeting the tumor microenvironment. The companys lead candidate, OR2805, has entered clinical studies with a unique and transformative approach to the advancement of cancer therapeutics. OncoResponse is based in Houston, Texas and Seattle, Washington

What is Oncoresponse's industry? +

Oncoresponse operates in the Research industry.

What is Oncoresponse's revenue? +

Oncoresponse's revenue is 1m - 10m

What is Oncoresponse's company size? +

Oncoresponse has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.